Author: Griensven J. Carrillo E. López-Vélez R. Lynen L. Moreno J.
Publisher: Blackwell Publishing
ISSN: 1198-743X
Source: Clinical Microbiology & Infection, Vol.20, Iss.4, 2014-04, pp. : 286-299
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Chagas disease in the immunosuppressed patient
Clinical Microbiology & Infection, Vol. 20, Iss. 4, 2014-04 ,pp. :
Leishmaniasis chemotherapy—challenges and opportunities
Clinical Microbiology & Infection, Vol. 17, Iss. 10, 2011-10 ,pp. :
Leishmaniasis impact and treatment access
By den Boer M. Argaw D. Jannin J. Alvar J.
Clinical Microbiology & Infection, Vol. 17, Iss. 10, 2011-10 ,pp. :
Visceral leishmaniasis: immunology and prospects for a vaccine
Clinical Microbiology & Infection, Vol. 17, Iss. 10, 2011-10 ,pp. :